(24/7 MARKET NEWS) – Altamira Therapeutics (NASDAQ: CYTO) shares are trading higher in this morning’s premarket, at $0.623, up $0.154 (+32.86%), on 3.66 million shares traded. Its July high of 66 cents is a key inflection point.
Altamira announced the publication of a peer-reviewed article in the scientific journal Pharmaceutics.
Altamira Therapeutic’s SemaPhore Platform Shown Particularly Effective in Intracellular mRNA Delivery for Cancer Therapy
https://finance.yahoo.com/news/altamira-therapeutics-semaphore-platform-shown-124700994.html
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
